Invention Grant
- Patent Title: Salt forms of URAT-1 inhibitors
-
Application No.: US17748134Application Date: 2022-05-19
-
Publication No.: US11685720B2Publication Date: 2023-06-27
- Inventor: Xing Dai , Yueheng Jiang
- Applicant: INVENTISBIO CO., LTD.
- Applicant Address: CN Shanghai
- Assignee: INVENTISBIO CO., LTD.
- Current Assignee: INVENTISBIO CO., LTD.
- Current Assignee Address: CN Shanghai
- Agency: Nixon & Vanderhye, P.C.
- Priority: WO TCN2018080889 2018.03.28
- Main IPC: C07D213/70
- IPC: C07D213/70 ; A61K31/426 ; A61K31/4418 ; A61K31/522

Abstract:
Provided herein are compounds, salts, crystalline forms, and pharmaceutical compositions that are related to thiobutyrate compounds, such as Compound (1) and its salts (such as sodium, potassium, and calcium salt), as well as methods of preparing the same. Also provided herein are methods of using the compounds, salts, crystalline forms, and pharmaceutical compositions for the treatment of diseases or disorders, such as gout and hyperuricemia.
Public/Granted literature
- US20220371996A1 NOVEL SALT FORMS OF URAT-1 INHIBITORS Public/Granted day:2022-11-24
Information query